Clinical Trials
All Clinical Trials - Page 23 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05487469N/AUnknown
Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass
Thymosin-Alpha-1
- NCT05339529N/ARecruiting
Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)
Thymosin-Alpha-1
- NCT05467514Phase 3Completed
Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus
Liraglutide
- NCT05430048Phase 2Completed
Nasal Desmopressin Versus Oral Bisoprolol for Controlling Bleeding During Endoscopic Sinus Surgery
Desmopressin
- NCT05431803N/ACompleted
Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China
Lanreotide
- NCT05281328Phase 2/Phase 3Active Not Recruiting
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
Octreotide
- NCT05400733N/ARecruiting
Prandial Metabolic Phenotype in Adults
KPV
- NCT04174755N/ARecruiting
Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
Semaglutide
- NCT05429593Phase 1Completed
A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet
Semaglutide
- NCT05412004Phase 3Completed
Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea
Tirzepatide
- NCT05348122Phase 2Unknown
A Study of TG103 Injection in Type 2 Diabetes Subjects
Dulaglutide
- NCT05407961Phase 1Completed
A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT05456854Phase 1Withdrawn
Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp
Kisspeptin
- NCT05377333Phase 1Completed
A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
Dulaglutide
- NCT03953170Phase 3Withdrawn
Pilot Study to Investigate the Effect of Teduglutide on Temporary Ileostomy Function and Complications
Teduglutide
- NCT05399173N/AUnknown
Effect of Laser Acupuncture for Treating Monosymptomatic Nocturnal Enuresis in Adolescent Females
Desmopressin
- NCT05352815Phase 3Completed
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec
Semaglutide
- NCT05478083Phase 2Recruiting
A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease
Gonadorelin
- NCT05418907N/AUnknown
Exendin PET/CT for Imaging of Paragangliomas
Exenatide
- NCT05199038Phase 4Unknown
Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study
Octreotide
- NCT05459285Phase 1Completed
A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects
Dulaglutide
- NCT05574439Phase 4Completed
Young Adults With Early-onset Obesity Treated With Semaglutide
Semaglutide
- NCT04941911Phase 2Unknown
A Feasibility Study of Octreotide Infusion During Liver Transplant.
Octreotide
- NCT05313802Phase 1Completed
A Study of LY3502970 in Healthy Overweight and Obese Participants
Orforglipron
- NCT05333003N/AActive Not Recruiting
Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
Semaglutide
- NCT05356104Phase 2Recruiting
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
Semaglutide
- NCT05291325N/ACompleted
Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy
Linaclotide
- NCT04760782Phase 2Terminated
PTH Analog Type II Odontoid Fracture
Abaloparatide
- NCT05364944Phase 1Terminated
A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Octreotide
- NCT05341089Phase 1Completed
A Study of Two Different Formulations of LY3502970 in Healthy Participants
Orforglipron
- NCT05369390Phase 1Completed
A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity
Amycretin
- NCT05147896N/AUnknown
Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
Semaglutide
- NCT06820047N/ACompleted
Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study
Semaglutide
- NCT05328843Phase 1Unknown
Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function
Exenatide
- NCT05307042N/AUnknown
Decline in Renal Concentration Ability in Lithium Treated Patients
Desmopressin
- NCT05162768Phase 3Completed
Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)
Elamipretide
- NCT05296733Phase 1Completed
A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906
Survodutide
- NCT05230589N/ACompleted
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practice
Semaglutide
- NCT05533632Phase 4Completed
Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes
Semaglutide
- NCT05361668Phase 2Completed
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Octreotide
- NCT05221229N/AActive Not Recruiting
Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
Liraglutide
- NCT05260021Phase 3Completed
A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
Tirzepatide
- NCT05259033Phase 3Completed
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
Semaglutide
- NCT05316662N/ACompleted
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice
Semaglutide
- NCT05230615N/ACompleted
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice
Semaglutide
- NCT05212857Phase 2Unknown
Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer
Gonadorelin
- NCT05370235Phase 2Unknown
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V
Afamelanotide
- NCT05207709Phase 3Terminated
Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype
Gonadorelin
- NCT05477576Phase 3Recruiting
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
Octreotide
- NCT04763564Phase 2Terminated
Efficacy of Liraglutide Therapy in Patients With IPAA
Liraglutide